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Most chronic diseases follow a socioeconomic gradient with higher rates in lower
socioeconomic groups. A growing body of research, however, reveals cancer to be a
disease group with very diverse socioeconomic patterning, even demonstrating reverse
socioeconomic gradients for certain cancers. To investigate this matter at the German
national level for the first time, this study examined socioeconomic inequalities in cancer
incidence in Germany, both for all cancers combined as well as for common site-specific
cancers. Population-based data on primary cancers newly diagnosed in 2010–2013 was
obtained from the German Centre for Cancer Registry Data. Socioeconomic position was
assessed at the district level using the German Index of Socioeconomic Deprivation,
which is a composite index of area-based socioeconomic indicators. Absolute and
relative socioeconomic inequalities in total and site-specific cancer incidence were
analyzed using multilevel Poisson regression models with the logarithm of the number
of residents as an offset. Among men, socioeconomic inequalities in cancer incidence
with higher rates in more deprived districts were found for all cancers combined and
various site-specific cancers, most pronounced for cancers of the lung, oral and upper
respiratory tract, stomach, kidney, and bladder. Among women, higher rates in more
deprived districts were evident for kidney, bladder, stomach, cervical, and liver cancer
as well as for lymphoid/hematopoietic neoplasms, but no inequalities were evident for
all cancers combined. Reverse gradients with higher rates in less deprived districts
were found for malignant melanoma and thyroid cancer in both sexes, and in women
additionally for female breast and ovarian cancer. Whereas in men the vast majority of
all incident cancers occurred at cancer sites showing higher incidence rates in more
deprived districts and cancers with a reverse socioeconomic gradient were in a clear
minority, the situation was more balanced for women. This is the first national study
from Germany examining socioeconomic inequalities in total and site-specific cancer
incidence. The findings demonstrate that the socioeconomic patterning of cancer is
diverse and follows different directions depending on the cancer site. The area-based
cancer inequalities found suggest potentials for population-based cancer prevention and
can help develop local strategies for cancer prevention and control.
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INTRODUCTION
With close to 480,000 incident cases in 2014 and causing
approximately 25% of all deaths, cancer is a major health
concern in Germany, as in practically all countries with high life
expectancies. Although age-specific and standardized mortality
rates for total cancer have been steadily declining since the mid-
1990s and incidence rates, at least for men, have been showing a
modest decrease in recent years, the absolute burden of cancer is
increasing due to population aging.
Social epidemiological research consistently shows that
socioeconomic position is an important determinant of health
and disease (1–5). The term “socioeconomic position” describes
the position that an individual or group holds within a vertically
structured society by referring to the social and economic factors
that influence this position, mainly education, employment, and
income (6, 7). Previous research indicates that socioeconomic
position exerts its effects on health through various pathways.
For instance, people with low socioeconomic position are more
likely to be exposed to health risks in the workplace and living
environment than those with higher socioeconomic position
(8–11). In addition, common lifestyle-related risk factors such
as tobacco smoking, physical inactivity, unhealthy diet, and
obesity are each more prevalent in lower socioeconomic groups
(12–17). As a consequence, people with low socioeconomic
position have an increased risk of severe and chronic health
conditions, which is ultimately reflected in a higher risk of
premature mortality and a lower life expectancy (3, 18–23).
The Organization for Economic Co-operation and Development
has recently estimated for 23 countries around the globe that,
on average, the gap in life expectancy between high and low
socioeconomic groups is 8 years for men and 5 years for women
at the age of 25 (24). Similar gaps in longevity have also been
reported for Germany (25–27).
Over recent decades, socioeconomic determinants have
increasingly moved into the focus of cancer epidemiology.
As early as 1997, the International Agency for Research on
Cancer summarized in a report on the existing evidence that
people with lower socioeconomic position tend to have higher
cancer incidence than those with high socioeconomic position,
although this pattern varies according to cancer site (28). Higher
rates in lower socioeconomic groups, typically referred to as
the socioeconomic gradient in health, have been found for a
variety of cancers, e.g., for cancers of the respiratory tract,
oral, and stomach cancer (29–33). A reverse socioeconomic
gradient with higher incidence in upper socioeconomic groups
has been reported especially for skin cancer and female breast
cancer (34–37). In addition, evidence from some high-income
countries shows that cancer contributes to a large proportion of
the gap in mortality and life expectancy between low and high
socioeconomic groups and that the proportion of the mortality
gap attributable to cancer has increased overall in recent decades
(38–40).
Evidence from Germany on socioeconomic inequalities in
cancer incidence is still scarce, but the few studies available are
largely consistent with those from other high-income countries
in suggesting a strong socioeconomic patterning of cancer
incidence for various cancer sites (41–44). However, the few
findings from Germany are limited to certain regions, such as
single German federal states, or to enrollees in one specific
statutory health insurance fund, and therefore do not reflect the
population as a whole. The only large-scale study from Germany
was restricted to inequalities in cancer survival (45). Moreover,
the existing studies from Germany have focused on relative
inequalities in cancer between socioeconomic groups, whereas
absolute inequalities have largely been neglected. The aims of
the present study were therefore to use nationwide data (1) to
analyze area-based socioeconomic gradients in the incidence of
cancer overall and common site-specific cancers among men
and women in Germany, and (2) to examine the magnitude
of absolute and relative socioeconomic inequalities in cancer
incidence for various cancer sites.
MATERIALS AND METHODS
Data Source and Study Population
The analyses were based on population-based registry data from
the German Centre for Cancer Registry Data at the Robert
Koch Institute. All German federal states maintain population-
based cancer registries that provide nationwide assessment of
incident primary cancers as well as mortality follow-up. Federal
and state laws regulate registry operations and practices. The
registries have been operating for various lengths of time,
the oldest of which is the Saarland Cancer Registry (since
1970) and the youngest of which is the cancer registry of
Baden-Württemberg (since 2009). Each registry transfers an
anonymized dataset annually to the Robert Koch Institute, where
the data undergo quality checks and are pooled for nationwide
and regional analyses. Additionally, registration completeness
is estimated by federal state, year and diagnosis group. These
estimates are based on comparisons of mortality-to-incidence
ratios, with established reference registries providing baseline
values. For the present analyses, cancer incidence data for the
years 2010 through 2013 were extracted from this pooled dataset.
These years were chosen so as to include reliable data from
Germany’s largest federal state, North Rhine-Westphalia, which
established statewide registration in 2005 and achieved good
completeness shortly thereafter. For cases identified only through
death certificate notification (DCO cases), the date of diagnosis
was set to the date of death. Data from four federal states (Baden-
Württemberg, Berlin, Hesse and Saxony-Anhalt) were excluded
from the present analyses due to low completeness estimates.
The included registries cover nearly 59 million residents in 317
German districts (Table 1), which is approximately 73 percent of
the total resident population of Germany.
Cancer Sites
The population-based cancer registries in Germany classify
cancer diagnoses based on both the tenth edition of the
International Classification of Diseases (ICD-10) and the third
edition of the International Classification of Diseases for
Oncology (ICD-O-3). For the present analyses, the group of all
cancers combined included primary malignant cancers without
non-melanoma skin cancers (ICD-10 codes C00–C43, C45–C76,
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TABLE 1 | Description of the study population and dataset, 2010–2013.
Men Women
Mean population size per year 28,757,742 29,975,640
Mean number of incident cancer cases per yeara 191,426 171,349
Number of first-level units in the data setb 22,824 22,824
Number of districts (second-level units) 317 317
Mean annual number of residents per district 90,718 94,560
–Deprivation quintile 1 (least deprived) 110,404 116,060
–Deprivation quintile 2 91,499 95,032
–Deprivation quintile 3 91,173 95,091
–Deprivation quintile 4 81,593 84,771
–Deprivation quintile 5 (most deprived) 78,603 81,497
Mean deprivation score of included districts
(with SD)
0.64 ± 0.16 0.64 ± 0.16
Mean deprivation score of excluded districts
(with SD)
0.56 ± 0.19 0.56 ± 0.19
aFor all cancer sites (C00–C97 without C44 and C77–C79).
bProduct of the number of age groups (n= 18), districts (n= 317), and observation years
(n = 4); SD, standard deviation.
and C80–C97). Individual cancer sites and cancer site groups
were defined according to the given ICD-10 codes. Bladder
cancers (C67) were analyzed both including and excluding in-situ
tumors (D09.0) and tumors of uncertain or unknown behavior
(D41.4).
Socioeconomic Deprivation
Area-based socioeconomic deprivation was measured at the
district level using the German Index of Socioeconomic
Deprivation (GISD), which has been developed by the Robert
Koch Institute for epidemiological research and health reporting
in Germany (46). In the present study, we used the second
version of the index, which is available for research purposes
free of charge at a GitHub repository (47). The index is
generally available for regional units at different spatial levels.
In this study, it was used at the level of German administrative
districts because this was the smallest spatial level that could
be analyzed in the nationally pooled cancer registry data used.
GISD is a composite index with three classic socioeconomic
dimensions: income, education and employment. The income
dimension is assessed by area-based mean net household income,
tax revenues and debtor quotas. The educational dimension
is ascertained using a district’s population share of employees
with university degree and the share of school dropouts without
certificate. In addition, during the revision of the index, the
share of school graduates with Abitur (German equivalent of the
International Baccalaureate) and the share of employees without
any secondary-school degree have been added. Indicators of the
employment dimension are the regional unemployment rate,
average gross wage of employees and labor force participation
rate. Factor analysis is used to weight the single indicators of
each dimension. The three dimensions are then given equal
weighting in the composite index, thus income, education and
employment each contribute one-third to the total index score. A
higher index score indicates higher socioeconomic deprivation,
i.e., lower socioeconomic position of a district’s population. All
districts included in our analysis were classified into quintiles of
socioeconomic deprivation by year according to their total index
scores (Figure 1). Further information about the methods and
data used in the development of the index have been published
elsewhere in detail (46).
Statistical Analysis
Incidence rates with 95% confidence intervals (CI) were
estimated as the number of newly diagnosed cancer cases per
100,000 residents, as predicted by Poisson regression analysis.
To account for the clustered and hierarchical structure of the
data (age groups nested within districts), multilevel models were
used with age groups as first-level and districts as second-level
units. The number of incident cancer cases registered within each
age group of a district was regressed on the districts’ level of
socioeconomic deprivation, with age group and calendar year as
covariates. Analyses were stratified by sex in order to identify
sex-specific patterns of socioeconomic inequalities in cancer
risk. In overall models for men and women together, sex was
added to the model as an additional covariate. The logarithm
of the population size in each age group was included in the
models as an offset term to account for the variable number of
persons under observation. To obtain age-standardized results,
each district’s age distribution was weighted to match the 2013
European Standard Population with a collapsed upper age band
of 85+ (48). For standard error estimation, the sample size was
defined as the total number of first-level units in the dataset
(n= 22,824).
Socioeconomic inequalities in cancer incidence were analyzed
by computing simple measures of pairwise group differences
by quintiles of socioeconomic deprivation (standardized rate
differences, standardized rate ratios) and more sophisticated
summary indices of inequality (slope index of inequality [SII],
relative index of inequality [RII]). While rate differences and SII
quantify the magnitude of absolute inequality, rate ratios and
RII represent the magnitude of relative inequality (49, 50). The
advantage of the regression-based SII and RII over the simple
measures is that they do not simply compare two extreme groups
(e.g., the most vs. least deprived quintile), but take into account
the association between a socioeconomic variable and a given
health outcome across the entire socioeconomic spectrum (50).
In other words, these measures make full use of all information
available, whereas the simple measures ignore parts of it. To
calculate the SII and RII, we used ridit scoring to convert the
socioeconomic deprivation index to a fractional rank variable
ranging from 0 (least deprived) to 1 (most deprived), which
was then entered into the regression model as an independent
variable (51, 52). The SII represents the absolute rate difference
and the RII the relative rate ratio between people living in the
most vs. least deprived districts. Thus, in the present study, they
compare the average cancer risk between districts at the very
bottom and very top of the regional socioeconomic distribution
while taking into account the risk in the intermediate districts
through the regression-based estimationmethod. Treemaps were
used to visualize the proportion of all incident cancers diagnosed
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FIGURE 1 | Map of Germany with districts included in the analysis, colored
according to their mean level of socioeconomic deprivation over the study
period, in quintiles (Geodata: © GeoBasis-DE / BKG 2018).
at each specific site in combination with the magnitude of its
absolute and relative inequality.
RESULTS
Table 2 presents the age-standardized incidence rates for all and
site-specific primary cancers, stratified by sex and quintiles of
socioeconomic deprivation. Results for the total population (i.e.,
men and women together) and additional cancer sites can be
found in the Supplementary Tables S1, S2. Among the male
population, area-based socioeconomic gradients were evident
for all cancers combined and a majority of the site-specific
cancers considered, with higher incidence rates in the most
deprived districts for cancers of the oral and upper respiratory
tract, esophagus, stomach, colorectum, pancreas, lung, kidney,
bladder, and lymphoid or hematopoietic neoplasms. Exceptions
were malignant melanoma and thyroid cancer incidence, which
followed a reverse gradient with higher rates in less deprived
districts. Among the female population, socioeconomic gradients
with higher rates in more deprived districts were evident
for stomach, liver, cervical, kidney, bladder, and lymphoid
or hematopoietic cancers. Reverse gradients with higher rates
among women in less deprived districts were found formalignant
melanoma, thyroid, breast and ovarian cancer. For these
cancers (expect for thyroid cancer), the incidence rates among
women did not show a consistent gradient, as the rates in
the middle deprivation quintile tended to be higher than in
the adjacent quintiles, a pattern also evident for male prostate
cancer.
Table 3 shows the measures of absolute inequalities
(standardized rate differences and SII) and relative inequalities
(standardized rate ratios and RII) in primary cancer incidence
by sex. Results for the total population and additional cancer
sites can be found in Supplementary Table S3. For the
overall category of all primary cancers, the age-standardized
incidence rate for men living in the most deprived quintile of
districts was 47 cases per 100,000 residents higher compared
to their counterparts in the least deprived quintile. This rate
difference was even larger (71 cases per 100,000 residents)
when districts at the very top and very bottom of the regional
socioeconomic spectrum were compared and the distribution
between them was taken into account, as indicated by the
SII. With regard to relative inequalities, the standardized
incidence rate was 7% higher among men in the most
deprived quintile compared to their counterparts in the
least deprived quintile. Again, the increase was larger (11%)
when the entire socioeconomic distribution was taken into
account, as reflected in the RII. Among men, lung cancer
and malignant melanoma showed the highest magnitudes
of absolute inequalities, although their socioeconomic
inequalities followed different patterns, with higher rates in
more deprived districts for lung cancer and a reverse gradient
for malignant melanoma. The largest relative inequalities among
men were found for thyroid cancer, malignant melanoma,
lung cancer, and cancers of the oral and upper respiratory
tract.
Among women, neither absolute nor relative inequalities were
found for the overall category of all primary cancers. When
considering site-specific incidence, however, socioeconomic
inequalities of varying degree and direction were evident for
many cancer types. The largest absolute inequalities—regardless
of the direction—were found for breast cancer and malignant
melanoma, both of which showed a lower incidence in the
most deprived districts. The largest relative inequalities among
women were evident for thyroid cancer, malignant melanoma,
and kidney cancer, with the latter showing higher rates in more
deprived districts.
The treemaps in Figure 2 visualize the proportion of incident
primary cancers diagnosed at each specific site over the study
period in combination with the pattern of its absolute and
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TABLE 2 | Age-standardized incidence rates among men and women by quintiles of district-level socioeconomic deprivation.
Quintiles of socioeconomic deprivation
1 (least deprived) 2 3 4 5 (most deprived)
SIR (95% CI) SIR (95% CI) SIR (95% CI) SIR (95% CI) SIR (95% CI)
ALL CANCERS (C00–C97)a
Men 648.7 (635.9–661.6) 664.9 (653.8–676.1) 686.8 (675.8–697.8) 691.8 (680.8–702.8) 695.9 (683.7–708.0)
Women 491.3 (480.7–501.8) 488.5 (479.6–497.3) 497.3 (488.6–505.9) 489.2 (480.7–497.8) 486.8 (477.5–496.1)
ORAL AND UPPER RESPIRATORY TRACT (C00–C06, C09–C14, C32)
Men 27.3 (25.9–28.6) 27.8 (26.5–29.1) 28.6 (27.3–29.9) 32.6 (31.2–34.0) 33.9 (32.3–35.4)
Women 7.8 (7.3–8.4) 7.8 (7.3–8.4) 8.0 (7.5–8.5) 7.6 (7.1–8.2) 8.3 (7.7–8.9)
ESOPHAGUS (C15)
Men 11.9 (11.3–12.6) 12.9 (12.2–13.6) 13.6 (12.9–14.3) 13.3 (12.6–13.9) 14.2 (13.5–14.9)
Women 3.1 (2.8–3.4) 3.0 (2.7–3.2) 3.3 (3.0–3.5) 3.0 (2.7–3.3) 2.8 (2.5–3.0)
STOMACH (C16)
Men 23.7 (22.8–24.7) 24.5 (23.6–25.5) 25.9 (24.9–26.9) 27.4 (26.4–28.4) 29.0 (27.9–30.0)
Women 12.6 (12.0–13.1) 13.7 (13.1–14.3) 13.5 (13.0–14.1) 14.0 (13.5–14.6) 14.7 (14.1–15.3)
COLORECTUM (C18–C20)
Men 88.1 (85.5–90.7) 92.2 (89.6–94.8) 93.8 (91.3–96.4) 94.3 (91.8–96.8) 94.5 (91.9–97.1)
Women 57.1 (55.3–59.0) 58.7 (56.9–60.5) 61.8 (60.0–63.6) 59.4 (57.6–61.1) 58.9 (57.1–60.7)
LIVER (C22)
Men 16.6 (15.5–17.7) 15.6 (14.6–16.5) 14.9 (14.0–15.8) 16.4 (15.4–17.4) 16.9 (15.9–17.9)
Women 5.0 (4.7–5.3) 5.2 (4.9–5.6) 4.8 (4.5–5.2) 5.3 (5.0–5.7) 5.8 (5.4–6.1)
PANCREAS (C25)
Men 22.5 (21.6–23.3) 21.2 (20.4–22.0) 21.6 (20.8–22.4) 22.5 (21.7–23.3) 24.0 (23.1–24.8)
Women 17.7 (17.2–18.3) 17.4 (16.8–18.0) 16.8 (16.3–17.4) 17.1 (16.5–17.6) 17.4 (16.8–18.0)
LUNG (C33–C34)
Men 77.4 (74.1–80.8) 85.1 (81.9–88.2) 93.1 (89.8–96.4) 99.9 (96.4–103.3) 103.1 (99.2–106.9)
Women 35.5 (33.1–37.9) 35.5 (33.5–37.6) 38.8 (36.7–41.0) 38.6 (36.4–40.7) 37.7 (35.4–40.0)
MALIGNANT MELANOMA OF SKIN (C43)
Men 31.6 (29.8–33.4) 30.0 (28.4–31.6) 28.4 (26.9–29.9) 25.0 (23.6–26.3) 22.9 (21.6–24.2)
Women 26.8 (25.0–28.7) 24.7 (23.2–26.2) 26.1 (24.6–27.6) 22.4 (21.0–23.7) 21.1 (19.6–22.5)
BREAST (C50)
Women 159.1 (154.6–163.7) 156.7 (152.7–160.6) 158.5 (154.6–162.3) 152.6 (148.9–156.3) 151.7 (147.8–155.7)
CERVIX UTERI (C53)
Women 10.9 (10.3–11.5) 10.7 (10.1–11.3) 11.3 (10.7–11.9) 12.5 (11.8–13.1) 12.1 (11.5–12.8)
OVARY (C56)
Women 17.1 (16.4–17.8) 17.3 (16.6–18.0) 17.6 (16.9–18.3) 16.6 (15.9–17.3) 15.9 (15.2–16.5)
PROSTATE (C61)
Men 168.8 (163.0–174.7) 170.8 (165.6–175.9) 178.8 (173.6–183.9) 170.6 (165.8–175.5) 173.1 (167.7–178.5)
KIDNEY (C64)
Men 23.3 (22.2–24.5) 24.8 (23.6–26.0) 24.6 (23.5–25.7) 27.2 (26.0–28.4) 28.3 (27.1–29.6)
Women 11.1 (10.5–11.7) 12.1 (11.4–12.7) 12.1 (11.5–12.8) 13.2 (12.6–13.9) 14.3 (13.6–15.0)
BLADDER (C67)
Men 27.7 (26.2–29.2) 29.4 (27.9–30.9) 30.9 (29.4–32.4) 31.9 (30.4–33.5) 33.2 (31.5–34.8)
Women 7.7 (7.2–8.2) 8.0 (7.5–8.6) 8.4 (7.9–8.9) 8.6 (8.1–9.1) 9.1 (8.6–9.7)
THYROID GLAND (C73)
Men 6.0 (5.5–6.5) 5.0 (4.5–5.4) 5.1 (4.7–5.5) 4.0 (3.6–4.3) 3.8 (3.5–4.2)
Women 12.4 (11.4–13.4) 11.4 (10.6–12.3) 10.5 (9.7–11.3) 8.4 (7.8–9.1) 9.5 (8.7–10.2)
LYMPHOID AND HEMATOPOIETIC NEOPLASMS (C81–C96)
Men 51.3 (49.3–53.3) 54.4 (52.4–56.4) 54.3 (52.4–56.2) 55.3 (53.4–57.3) 56.3 (54.3–58.4)
Women 33.7 (32.4–35.0) 35.9 (34.6–37.3) 36.5 (35.2–37.8) 37.0 (35.7–38.3) 37.6 (36.2–38.9)
aWithout C44 and C77–C79; CI, confidence interval; SIR, standardized incidence rate; All rates are predictive margins (predicted cases per 100,000 residents) from multilevel Poisson
regression models, weighted according to the 2013 European Standard Population.
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TABLE 3 | Absolute and relative inequalities in cancer incidence among men and women by district-level socioeconomic deprivation.
Simple measures Summary indices
SRD (95% CI) SRR (95% CI) p-value SII (95% CI) RII (95% CI) p-value
ALL CANCERS (C00–C97)a
Men 47.1 (29.7–64.6) 1.07 (1.05–1.10) <0.001 71.3 (47.8–94.9) 1.11 (1.07–1.15) <0.001
Women −4.5 (−18.3–9.4) 0.99 (0.96–1.02) 0.526 −7.5 (−26.4–11.5) 0.98 (0.95–1.02) 0.440
ORAL AND UPPER RESPIRATORY TRACT (C00–C06, C09–C14, C32)
Men 6.6 (4.5–8.6) 1.24 (1.16–1.33) <0.001 9.8 (7.3–12.2) 1.38 (1.28–1.50) <0.001
Women 0.5 (−0.3–1.3) 1.06 (0.96–1.17) 0.246 0.4 (−0.5–1.3) 1.05 (0.94–1.17) 0.403
ESOPHAGUS (C15)
Men 2.3 (1.3–3.2) 1.19 (1.11–1.28) <0.001 2.5 (1.4–3.6) 1.21 (1.11–1.31) <0.001
Women −0.3 (−0.7–0.1) 0.90 (0.79–1.02) 0.106 −0.3 (−0.8–0.1) 0.89 (0.77–1.04) 0.141
STOMACH (C16)
Men 5.2 (3.8–6.6) 1.22 (1.16–1.29) <0.001 6.7 (5.1–8.2) 1.29 (1.22–1.37) <0.001
Women 2.2 (1.3–3.0) 1.17 (1.10–1.24) <0.001 2.4 (1.5–3.3) 1.19 (1.12–1.27) <0.001
COLORECTUM (C18–C20)
Men 6.4 (2.8–10.1) 1.07 (1.03–1.12) 0.001 8.0 (3.6–12.4) 1.09 (1.04–1.14) <0.001
Women 1.7 (−0.9–4.3) 1.03 (0.99–1.08) 0.189 2.5 (−0.6–5.7) 1.04 (0.99–1.10) 0.115
LIVER (C22)
Men 0.3 (−1.2–1.7) 1.02 (0.93–1.11) 0.714 0.4 (−1.3–2.1) 1.03 (0.92–1.14) 0.632
Women 0.8 (0.3–1.3) 1.16 (1.06–1.27) 0.001 0.8 (0.3–1.4) 1.17 (1.06–1.29) 0.003
PANCREAS (C25)
Men 1.5 (0.3–2.7) 1.07 (1.01–1.12) 0.015 1.9 (0.6–3.3) 1.09 (1.03–1.16) 0.005
Women −0.3 (−1.1–0.5) 0.98 (0.94–1.03) 0.477 −0.4 (−1.3–0.5) 0.98 (0.93–1.03) 0.379
LUNG (C33–C34)
Men 25.6 (20.5–30.7) 1.33 (1.26–1.41) <0.001 37.1 (30.5–43.7) 1.50 (1.40–1.61) <0.001
Women 2.2 (−1.0–5.5) 1.06 (0.97–1.16) 0.183 2.7 (−1.7–7.0) 1.07 (0.96–1.21) 0.232
MALIGNANT MELANOMA OF SKIN (C43)
Men −8.7 (−10.9–−6.5) 0.72 (0.67–0.79) <0.001 −12.3 (−15.0–−9.5) 0.64 (0.58–0.71) <0.001
Women −5.8 (−8.1–−3.5) 0.78 (0.71–0.86) <0.001 −8.3 (−11.3–−5.4) 0.71 (0.63–0.80) <0.001
BREAST (C50)
Women −7.4 (−13.4–−1.4) 0.95 (0.92–0.99) 0.016 −12.0 (−19.6–−4.4) 0.93 (0.88–0.97) 0.002
CERVIX UTERI (C53)
Women 1.3 (0.4–2.2) 1.12 (1.03–1.21) 0.005 2.0 (1.0–3.0) 1.19 (1.09–1.30) <0.001
OVARY (C56)
Women −1.2 (−2.2–−0.2) 0.93 (0.87–0.99) 0.016 −1.7 (−2.9–−0.6) 0.90 (0.84–0.97) 0.003
PROSTATE (C61)
Men 4.3 (−3.6–12.2) 1.03 (0.98–1.07) 0.286 2.6 (−7.7–12.9) 1.02 (0.96–1.08) 0.623
KIDNEY (C64)
Men 5.0 (3.3–6.6) 1.21 (1.14–1.29) <0.001 6.3 (4.3–8.3) 1.28 (1.18–1.38) <0.001
Women 3.2 (2.2–4.1) 1.28 (1.19–1.38) <0.001 4.1 (3.1–5.2) 1.39 (1.28–1.51) <0.001
BLADDER (C67)
Men 5.5 (3.3–7.7) 1.20 (1.11–1.29) <0.001 7.4 (4.7–10.0) 1.27 (1.17–1.39) <0.001
Women 1.4 (0.6–2.2) 1.18 (1.08–1.29) <0.001 1.6 (0.7–2.4) 1.21 (1.09–1.34) <0.001
THYROID GLAND (C73)
Men −2.2 (−2.8–−1.6) 0.64 (0.57–0.72) <0.001 −2.8 (−3.4–−2.1) 0.56 (0.49–0.64) <0.001
Women −3.0 (−4.2–−1.7) 0.76 (0.68–0.85) <0.001 −5.1 (−6.5–−3.6) 0.62 (0.54–0.70) <0.001
LYMPHOID AND HEMATOPOIETIC NEOPLASMS (C81–C96)
Men 5.0 (2.2–7.9) 1.10 (1.04–1.16) 0.001 5.5 (2.1–9.0) 1.11 (1.04–1.18) 0.002
Women 3.8 (2.0–5.7) 1.11 (1.06–1.17) <0.001 4.2 (2.0–6.5) 1.12 (1.06–1.20) <0.001
aWithout C44 and C77–C79; SRD, standardized rate difference (most vs. least deprived quintile); SRR, standardized rate ratio (most vs. least deprived quintile); SII, Slope index of
inequality; RII, relative index of inequality; CI, confidence interval. All measures are age–standardized according to the 2013 European Standard Population.
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FIGURE 2 | Treemaps showing the proportion of all incident cancers diagnosed at each specific site (box size) in combination with the magnitude and direction of a)
absolute inequality and b) relative inequality (color). SII, slope index of inequality, RII, relative index of inequality; CNS, central nervous system; URT, upper respiratory
tract; LHN, lymphoid and hematopoietic neoplasms; Esoph., esophagus.
relative inequality by socioeconomic deprivation. In men, 90.1%
of all incident cancers occurred at cancer sites showing absolute
inequalities to the detriment of the most deprived (green); 4.5%
at cancer sites with absolute inequalities to the detriment of
the least deprived (blue). In women, these proportions were
46.5 and 40.3%. In respect of relative inequalities, 66.5% of all
cancers in men arose at sites with relative inequalities to the
detriment of the most deprived (green); 4.5% were cancer sites
with relative inequalities to the detriment of the least deprived
(blue). For women, these proportions were 35.8% and 40.9%,
reflecting that breast and ovarian cancer with their reverse




To our knowledge, this is the first study using representative
data for the vast majority of Germany’s population to examine
area-based socioeconomic inequalities in the incidence of cancer
overall and for a variety of site-specific cancers. For all cancers
combined, we found a socioeconomic gradient with higher
incidence rates in more deprived districts for men but not for
women. A closer look at site-specific cancers, though, showed
that in both men and women, socioeconomic inequalities in
cancer incidence do exist for several cancer sites, although
their patterns differ between cancer sites, especially in women.
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The majority of cancers among men followed a socioeconomic
gradient on both the absolute and relative scale with higher
rates in more deprived districts, most pronounced for cancers
of the lung, oral and upper respiratory tract, stomach, kidney,
and bladder. Among women, this pattern was found for cancers
of the kidney, bladder, stomach, and cervix uteri. Malignant
melanoma of the skin and thyroid cancer were exceptions in
both sexes as they showed a reverse socioeconomic gradient with
the highest incidence in the least deprived districts. This pattern
was also observed for female breast cancer and less clearly for
ovarian cancer. Whereas in men, most incident cancers were
diagnosed at sites showing a gradient to the detriment of the
most deprived, in women the shares of incident cancers showing
this gradient and of those with a reverse gradient were more
balanced.
Comparison With Previous Research and
Possible Explanations
Our findings support a large and growing body of evidence
indicating for various countries that the incidence of cancer
is unequally distributed across socioeconomic groups (28, 37,
53, 54). To a large extent, our results are consistent with
previous findings from various countries, which have found
higher incidence rates in lower socioeconomic groups for a
variety of site-specific cancers, e.g., for respiratory tract, oral and
stomach cancers (29–33). The reverse socioeconomic gradients
in melanoma, female breast cancer and thyroid cancer have
been found in other countries before as well (34–37, 55, 56). In
addition, our findings largely support those of the few previous
studies from Germany. Eberle et al. analyzed socioeconomic
inequalities in cancer incidence in Bremen, a major city in
northern Germany (42). For all cancers combined, they reported
a socioeconomic gradient for men, with higher incidence rates in
more deprived town districts, but not for women. Furthermore,
they found higher incidence rates for tumors of the oral cavity
and pharynx as well as for lung, cervical, and bladder cancers in
more deprived town districts and a reverse gradient for female
breast cancer, skin and prostate cancer, which is, except for
prostate cancer, very much in line with our findings. Kuznetsov
et al. examined area-based socioeconomic inequalities in lung
and colorectal cancer incidence in Bavaria, a southern German
federal state (43, 57). Their results indicate an excess risk in
more deprived areas for lung cancer in men and for colorectal
cancer in both men and women. Geyer used individual data
from one of the German statutory health insurance funds. He
found that individuals from the lowest socioeconomic group
had increased risks of lung, stomach and intestinal cancer (41).
For female breast cancer incidence, however, no socioeconomic
gradient was evident in the statutory health insurance data. This
may have been related to the fact that high socioeconomic groups
are underrepresented in the German statutory health insurance,
which is especially the case with the particular insurance fund
considered in the study (41, 58).
The literature suggests several explanations for socioeconomic
inequalities in cancer risk, including unequal distribution of
lifestyle-related risk factors, occupational, and environmental
exposures, reproductive and healthcare factors. In many
countries around the globe, common lifestyle-related cancer
risk factors such as tobacco smoking, unhealthy diets, physical
inactivity, and obesity aremore prevalent in lower socioeconomic
groups (12–17). Accordingly, these factors are often adduced
to explain the socioeconomic patterning of cancer. Tobacco
smoking, for instance, has been found to explain a major part of
socioeconomic inequalities in the incidence of lung cancer (59),
but also has explanatory value for socioeconomic inequalities
in cancers at other sites (60–62). Regarding overall cancer
mortality instead of site-specific cancer incidence, smoking has
been found to explain the greatest proportion of the association
with area-level socioeconomic deprivation, followed by diet,
physical activity, cancer screening behaviors and body-mass-
index (63). The fact that we found a socioeconomic gradient in
lung cancer incidence for men but not for women is probably
due to differences in the evolution of the socioeconomic gradient
in smoking habits by sex. Research from Germany suggests that
the socioeconomic gradient in smoking among men had already
developed early in the 20th century, whereas among women it
emerged much later toward the end of the century (64, 65). This
difference might lead to a delay of several decades before the
socioeconomic gradient in lung cancer also becomes apparent in
women. Alcohol consumption has also been found to partially
explain socioeconomic inequalities in different cancers (60, 62,
66, 67), but its contribution may generally be smaller than that
of smoking. This may partly be due to the fact that fewer cancer
cases are attributable to alcohol compared to tobacco (68, 69), but
also because alcohol consumption shows only minor variation
across socioeconomic groups (70), which has also been found
in the German population (71). Conway et al. have found that
smoking, alcohol consumption and diets low in fresh fruits and
vegetables together explain around two-thirds of the excess risk
for upper aerodigestive tract cancer in the lowest socioeconomic
group (62). From the unexplained excess risk they conclude that
low socioeconomic position seems to be associated with cancer
risk for reasons other than only through behavioral risk factors.
In addition to lifestyle factors, the contributions of carcinogen
exposure at work and in the living environment to socioeconomic
inequalities in cancer risk have also been examined (60). The
findings of Menvielle et al. suggest that a substantial proportion
of the socioeconomic gap in hypopharyngeal and laryngeal
cancer is attributable to occupational exposures to asbestos, coal
dust and formaldehyde (60). This finding was supported in a
study by Santi et al. who found that exposure to potentially
carcinogenic agents at work can explain approximately a quarter
of the socioeconomic inequalities in laryngeal cancer (67).
Another study showed that occupational exposures to asbestos,
heavy metals and polycyclic aromatic hydrocarbons can explain
parts of the association between socioeconomic position and
lung cancer incidence among men, with asbestos making the
largest contribution (72). However, it is not only the workplace
where members of lower socioeconomic groups are exposed
to carcinogenic agents. Exposures to air pollution in the living
environment or tobacco smoke at home can also contribute
to socioeconomic inequalities in the risk of respiratory tract
cancers (73).
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According to a systematic review (36), the reverse gradient
in female breast cancer incidence may be primarily explained
by reproductive factors. Women with higher socioeconomic
position are more likely to be older at first birth and have
lower parity, each of which is associated with increased breast
cancer risk. Socioeconomic differentials in the use of hormone
replacement therapy may also play a role in this context (74),
and could also help explain the reverse gradient in ovarian
cancer. Concerning the reverse gradient in melanoma of the skin,
a systematic review suggests that lifestyle-related risk factors,
including recreational sun exposure and tanning, may explain
why higher socioeconomic groups show higher melanoma
incidence (75).
Mechanisms related to healthcare should not be neglected
when it comes to explaining socioeconomic inequalities in
cancer incidence, especially when the findings are based on
population-based registry data. The reverse gradient in thyroid
cancer, for instance, is hypothesized to be attributable to new
diagnostic capabilities, which may have led to overdiagnosis and
increases in thyroid cancer incidence that have been observed
in recent decades (56, 76). As with previous innovations in
disease prevention and early disease detection such as the polio
vaccine or the pap test (77), innovative diagnostic tools for
thyroid cancer detection are likely to be used more often by
people from higher socioeconomic groups—at least in the first
years after launch—, consequently resulting in higher incidence
rates among the better-off. Moreover, the uptake of general
health checks and participation in cancer screening has often
been found to vary between socioeconomic groups, usually with
highest participation rates in middle or upper socioeconomic
groups (78–80). This has also been the case for Germany’s cancer
screening programs during our study period (81). Accordingly,
socioeconomic differentials in screening participation may have
contributed, at least in part, to the reverse socioeconomic
gradients or peak incidence in middle socioeconomic groups we
observed for certain cancers. For example, Germany introduced a
nationwide skin cancer screening program in 2008, and is thus, to
our knowledge, the only country worldwide with such a program
on a nationwide scale (82). Melanoma incidence increased in
Germany after screening was introduced (83), and screening
participation has been higher in the upper socioeconomic groups
(84). Therefore, screening may have contributed to our finding of
a higher melanoma incidence in less deprived districts. Similarly,
Germany has a nationwide mammography screening program
for the early detection of female breast cancer, and regular
screening participation has been found to be highest in the
middle and upper socioeconomic groups (81). Mammography
screening may thus also have contributed to our finding that the
incidence of breast cancer was highest in the middle and at the
top of the socioeconomic spectrum.
Strengths and Limitations
Our study contributes to the growing interest in analyzing
the association between socioeconomic deprivation and cancer.
The findings extend those from previous German studies
by providing results that are nearly nationally representative,
covering 73% of Germany’s total population, 12 of the 16
German federal states and 317 of the 402 administrative districts.
Previous studies have either been restricted to one federal state
or the population of one specific statutory health insurance fund.
Including the vast majority of the German population regardless
of health insurance status [people with private health insurance
have on average a higher socioeconomic position (58)] resulted
in greater socioeconomic heterogeneity of the study population.
A strength of the socioeconomic deprivation index used in
the present study is that it is based exclusively on the three core
dimensions of socioeconomic inequality (education, income, and
employment). This facilitates the interpretation of results (46),
especially when compared to indices of multiple deprivation
that include domains going beyond purely socioeconomic ones,
such as social capital, the share of lone-parent households,
crime rates, the physical environment or morbidity (85–87).
Another advantage of the index used is its public availability,
which makes the analysis more easily reproducible. Nevertheless,
the composite nature of the index also has some limitations.
Analogous to socioeconomic indices at the individual level,
composite measures generally have the disadvantage that they
can conceal variation in the associations of the single dimensions
with the health outcome under study (88). For example, if
education were to predict a health outcome such as cancer,
income or employment might not. This possibility should be
considered when interpreting our results.
It should further be considered that the area-based measure
of socioeconomic deprivation is prone to misclassification
of subjects when interpreting it at the individual level.
The socioeconomic groups in our study were classified by
an area-based index, because individual-level information on
socioeconomic position was not available in the cancer registry
and population data. For example, the area-based approach
classifies individuals with high socioeconomic position into the
socioeconomically most deprived group when they live in a
district with a high share of inhabitants of low socioeconomic
position. Therefore, it cannot be inferred directly from our results
that individuals of low or high socioeconomic position have
higher or lower cancer incidence. Depending on the degree of this
misclassification, which cannot be quantified with the data used,
the area-based approach may have led to an underestimation
of cancer inequalities with regard to individual socioeconomic
position in our study. However, the area-based approach helps
to identify regions whose populations, from a public health
perspective, may have an increased need for cancer prevention
measures with respect to specific cancers, although the large size
and heterogeneity of some districts may be challenging in this
respect.
We compared current cancer incidence with current district-
level socioeconomic deprivation. This does not account for
changes in a district’s deprivation over time, nor does it
account for population migration between districts with different
deprivation levels. Therefore, although the GISD is fairly stable
over time [intra-class correlation (ICC2010−2013) = 0.989] and
current socioeconomic deprivation may be associated with
utilization of certain diagnostic and early detection services,
our analyses do not provide a complete picture of the
etiologic relevance of socioeconomic deprivation for cancer
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incidence. Moreover, considering that a large proportion of
highly deprived districts are located in Eastern Germany,
it would have been desirable to discriminate the effects of
living in a currently deprived district from the effect of being
born and raised in the former German Democratic Republic.
Since we lacked the necessary background variables in the
registry data, we were not able to gain any insights into this
matter.
It should be considered that excluding data from four German
federal states may have introduced bias into our results. We
decided to exclude data from Hesse, Saxony-Anhalt, Baden-
Württemberg and Berlin because of insufficient registration
completeness (estimated completeness <90%). Therefore, the
extent of any associations between socioeconomic deprivation
and cancer incidence in these regions remains unknown. The
districts excluded from the analysis differed from the included
districts in having on average lower deprivation scores and a
larger heterogeneity (see Table 1), which may have introduced
potential selection bias.
Another limitation is related to the heterogeneity of
the included districts. In Germany, administrative units at
the district level vary considerably in their population size,
population density and socioeconomic diversity. Therefore
the Modifiable Area Unit Problem (MAUP) (89) has to
be taken into account: the MAUP postulates that different
regional aggregations of the units of observation may lead
to different results and conclusions. However, it has been
shown that district-level estimates of the socioeconomic
gradient in health for Germany, such as those presented here,
tend to find less pronounced associations than estimates at
smaller levels of spatial aggregation because differences in
deprivation between districts are less pronounced than, for
example, differences between individual towns or neighborhoods
(46). Therefore, it seems likely that our results, which are
in some instances based on districts with more than a
million inhabitants (large metropolitan cities forming one
independent administrative district), tend to underestimate
the association between socioeconomic deprivation and cancer
incidence.
Conclusions
Socioeconomic inequalities in the incidence of common cancers
demonstrate potentials for population-based cancer prevention.
In view of the major risk factors of common cancers and
the explanatory approaches discussed, both behavioral and
structural prevention strategies should be identified to reduce
socioeconomic differences in morbidity and mortality. In
accordance with the health-in-all-policies approach, these should
be implemented not only in the health sector, but in all
policy areas. The area-based cancer inequalities found in
our study can help to identify districts with high rates of
certain cancers and to develop local and community-based
strategies for cancer prevention and control. In future studies,
more in-depth analyses including additional data on tumor
stage and cancer mortality could provide additional insights
into the social epidemiology of cancer and potential entry
points for reducing the health gap between the better- and
worse-off.
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